Pharmaceutical R&D Trends 2025: Industry Insights and Strategic Shifts

Pharma R&D Trends 2025: Key Insights and Strategic Shifts The pharmaceutical industry is at a critical inflection point in 2025, with research and development (R&D) continuing to grow despite global…

Continue ReadingPharmaceutical R&D Trends 2025: Industry Insights and Strategic Shifts

Leveraging Comparative Evaluation in Due Diligence of Biopharma In-Licensing and Partnering Deals

Enhancing Biopharma Licensing and Partnering Through Comparative Evaluation The biopharmaceutical industry landscape is constantly evolving, and in-licensing and partnering deals are vital corporate strategies for driving innovation, devising new products,…

Continue ReadingLeveraging Comparative Evaluation in Due Diligence of Biopharma In-Licensing and Partnering Deals

New Product Planning Strategies for Pharma and Biotech Post Inflation Reduction Act

Finessing Pharma and Biotech Product Strategies in the Post-Inflation Reduction Act Era The recent passage of the Inflation Reduction Act (IRA) introduces sweeping changes for the biopharmaceutical industry through new…

Continue ReadingNew Product Planning Strategies for Pharma and Biotech Post Inflation Reduction Act